Study to Assess the Changes in Blood Clotting Factors and Blood Vessel Wall Function in Obstructive Sleep Apnea
NCT00936481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34
Last updated 2013-10-25
Summary
Obstructive sleep apnea is a condition in which people have decreased breathing during their sleep. Untreated sleep apnea has been linked to increased risk for cardiovascular diseases.
This research study is looking at blood clotting factors and blood vessel function in health volunteers and patients with newly diagnosed or untreated obstructive sleep apnea to better understand the underlying mechanisms for increased cardiovascular risk.
Conditions
Sponsors & Collaborators
-
Vanderbilt University
lead OTHER
Principal Investigators
-
Kanika Bagai, M.D · Vanderbilt University Medical Center, Nashville, TN
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2012-04-30
- Completion
- 2012-04-30
Countries
- United States
Study Locations
More Related Trials
-
New Markers to Measure Clotting in Patients With the Obstructive Sleep Apnoea Hypopnoea Syndrome
NCT01525160 ·Status: COMPLETED
-
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
NCT00984308 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sleep Apnea and Vascular Function
NCT01717339 ·Status: COMPLETED ·Phase: NA
-
Oxygen Saturation Monitoring During Surgery
NCT01098851 ·Status: COMPLETED
-
Influence of Sleep Apnea on Risk of Atrial Fibrillation
NCT02576587 ·Status: COMPLETED ·Phase: NA
-
Oxidative Stress and Endothelial Dysfunction in Obstructive Sleep Apnea
NCT00646971 ·Status: TERMINATED ·Phase: NA
-
Prospective Observational Registry for Obstructive Sleep Apnea in Patients With Acute Myocardial Infarction
NCT03600246 ·Status: COMPLETED
-
Sleep Apnea and Tromboembolic Disease
NCT00501358 ·Status: UNKNOWN
-
Vascular Pathophysiology in Obstructive Sleep Apnea
NCT00214084 ·Status: WITHDRAWN ·Phase: NA
-
Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea (OSA) and Effect of 6-month CPAP Treatment
NCT01312168 ·Status: UNKNOWN ·Phase: NA
-
Endothelial Function in Obstructive Sleep Apnea
NCT03122639 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness
NCT00393913 ·Status: COMPLETED
-
the Pathophysiology of the Onset of Atrial Fibrillation in Obstructive Sleep Apnea
NCT06246825 ·Status: ENROLLING_BY_INVITATION
-
Microparticles in Obstructive Sleep Apnea
NCT03438149 ·Status: RECRUITING
-
Biomarkers for Obstructive Sleep Apnea
NCT00834509 ·Status: COMPLETED
-
Sleep Apnea in a Non-Clinical Population
NCT00005551 ·Status: COMPLETED
-
Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome
NCT00456287 ·Status: UNKNOWN ·Phase: NA
-
Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment
NCT02583906 ·Status: TERMINATED ·Phase: NA
-
Obstructive Sleep Apnea and Endothelial Function in Patients With Resistant Hypertension
NCT01854190 ·Status: COMPLETED
-
CPAP Effect on Blood Pressure and Arterial Stiffness in Obstructive Sleep Apnea Patients With Resistant Hypertension
NCT02385864 ·Status: UNKNOWN
-
Effect of Obstructive Sleep Apnea on Central Blood Pressure and Kidney and Endothelial Function
NCT00947479 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea
NCT00859950 ·Status: COMPLETED ·Phase: NA
-
Vascular Endothelial Dysfunction in Sleep Apnea
NCT05289063 ·Status: RECRUITING ·Phase: PHASE1
-
Obstructive Sleep Apnea in the Absence of Metabolic Syndrome
NCT01635010 ·Status: COMPLETED ·Phase: PHASE4
-
Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea
NCT00438412 ·Status: SUSPENDED